Template:GHB background: Difference between revisions

Line 7: Line 7:
**euphoric, sexual, stimulant, and relaxant effects
**euphoric, sexual, stimulant, and relaxant effects
**Surreptitious drugging to facilitate sexual assault
**Surreptitious drugging to facilitate sexual assault
*Also used therapeutically in the treatment of narcolepsy<ref>Mamelak M, Scharf MB, Woods M. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep. 1986;9(1 Pt 2):285-289. doi:10.1093/sleep/9.1.285</ref>


===Pharmacokinetics===
===Pharmacokinetics===

Revision as of 16:29, 17 February 2021

Background

  • Abbreviation: GHB
  • Central nervous system depressant
  • GABA-B agonist (as opposed to GABA-A agonists - alcohol, benzodiazepines, etc)
  • Abused for:
    • Body building or sleep enhancement
    • euphoric, sexual, stimulant, and relaxant effects
    • Surreptitious drugging to facilitate sexual assault
  • Also used therapeutically in the treatment of narcolepsy[1]

Pharmacokinetics

  • effect starts in 15-20min, peaks in 30-60 min,
  • lipid soluble, no protein binding so crosses BBB readily
  • elimination is dose-dependent with half life of 20-50 min
  • The duration of GHB's clinical effects depends upon the dose, and ranges from 2.5 to 4 hours

Pharmacology

  • Is a metabolite and precursor of GABA
  • Interacts with GHB-specific receptors and also acts as a direct agonist of GABA-B receptors
  • Affects multiple neurotransmitter systems, including those of opioids, dopamine, serotonin, glutamate, and acetylcholine
  • Gamma butyrolactone (GBL) and 1,4 butanediol (BD) are GHB analogs that are rapidly metabolized to GHB after ingestion, with the same toxic and recreational effects
  1. Mamelak M, Scharf MB, Woods M. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep. 1986;9(1 Pt 2):285-289. doi:10.1093/sleep/9.1.285